Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Banque Nationale de Belgique | BNB | May 22, 2024 | 480.00 | +2.13 |
Barco NV | BAR | May 22, 2024 | 12.95 | -0.08 |
Basilix | BAS | May 22, 2024 | 11.40 | 0.00 |
Beaulieu Av Certificates | BEAB | May 22, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | May 22, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | May 22, 2024 | 3 996.70 | +0.14 |
Belreca - Belgian Resources and Capital Company | BELR | May 22, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | May 22, 2024 | 1.08 | 0.00 |
Belysse Group N.V. | BELYS | May 22, 2024 | 0.83 | -2.35 |
Biocartis Group NV | BCART | May 22, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | May 22, 2024 | 0.02 | +6.21 |
Biotalys | BTLS | May 22, 2024 | 3.05 | -0.65 |
Boeing | BOEI | May 22, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 22, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 22, 2024 | 3.29 | -0.30 |
Brederode S.A. | BREB | May 22, 2024 | 113.20 | +0.53 |
Campine nv | CAMB | May 22, 2024 | 79.00 | +0.64 |
Candela Invest | CAND | May 22, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | May 22, 2024 | 14.98 | +0.54 |
Celyad Oncology SA | CYAD | May 22, 2024 | 0.32 | +6.16 |
Cenergy Holdings | CENER | May 22, 2024 | 8.54 | -3.50 |
Chevron | CHTEX | May 22, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 22, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 22, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 22, 2024 | 61.05 | +0.33 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 22, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 22, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 22, 2024 | 45.42 | +4.13 |
Compagnie du Bois Sauvage S.A. | COMB | May 22, 2024 | 270.00 | -0.74 |
Compagnie d`Entreprises CFE SA | CFEB | May 22, 2024 | 7.50 | +0.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.